ARTICLE | Clinical News
Phenserine: Completed Phase II trial
October 8, 2001 7:00 AM UTC
Axonyx Inc. (AXYX), New York, N.Y. Product: Phenserine Business: Neurological Therapeutic category: Neurotransmission Target: Acetylcholinesterase Description: Oral reversible acetylcholinesterase in...